Pieris Pharmaceuticals Stock Quote PIRS - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

12.1383

Bid

11.77

Ask

12.00

Volume

7,097

11.755 Day's Range 12.1383

10.888 52 Week Range 80.80

Market Cap

1.18B

Previous Close

11.72

Open

11.94

Last Trade

11.87

Last Trade Time

11:26:20

Financial Volume

$ 84,134

VWAP

11.8549

Average Volume (3m)

679,851

Shares Outstanding

98,851,927

Dividend Yield

PE Ratio

-48.09

Earnings Per Share (EPS)

-0.25

Revenue

42.81M

Net Profit

-24.54M

Pieris Pharmaceuticals Inc is a clinical-stage biopharmaceutical company, which engages in the discovery and development of the Anticalin class of biotherapeutics. Anticalin proteins are engineered versions of lipocalins, human proteins that naturally bind, store and transport a wide spectrum of mol... Pieris Pharmaceuticals Inc is a clinical-stage biopharmaceutical company, which engages in the discovery and development of the Anticalin class of biotherapeutics. Anticalin proteins are engineered versions of lipocalins, human proteins that naturally bind, store and transport a wide spectrum of molecules. The company with the help of technology creates differentiated drugs such as PRS-080, PRS-060, PRS-343, and PRS-332 that can help patients suffering from cancer, severe asthma, anemia, and other medical conditions with a high unmet medical need. Geographically, all the operation of the firm functions through the region of the United States. Show more

Sector

Coml Physical, Biologcl Resh

Industry

Coml Physical, Biologcl Resh

Website

www.pieris.com

Headquarters

Las Vegas, Nevada, USA

Founded

1970

Pieris Pharmaceuticals Inc is listed in the Coml Physical, Biologcl Resh sector of the NASDAQ with ticker PIRS. The last closing price for Pieris Pharmaceuticals was $11.72. Over the last year, Pieris Pharmaceuticals shares have traded in a share price range of $ 10.888 to $ 80.80.

Pieris Pharmaceuticals currently has 98,851,927 shares outstanding. The market capitalization of Pieris Pharmaceuticals is $1.18 billion. Pieris Pharmaceuticals has a price to earnings ratio (PE ratio) of -48.09.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.4823	4.13778311599	11.656	12.93	11.155	415337	11.70908035	CS
4	-3.0617	-20.1427631579	15.2	15.2	11.04	493850	12.87313572	CS
12	-2.7417	-18.4254032258	14.88	22.32	11.04	679851	14.67477946	CS
26	-5.7017	-31.9602017937	17.84	23.2	10.888	580745	14.75938822	CS
52	-48.5017	-79.9830145119	60.64	80.8	10.888	1449635	25.02666909	CS
156	-171.8617	-93.4030978261	184	492	10.888	1713135	214.25392731	CS
260	-237.4617	-95.1368990385	249.6	496	10.888	1220531	223.28461135	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CAUDCollective Audience Inc	$ 0.7055 (80.90%)	100.9M
DCPHDeciphera Pharmaceuticals Inc	$ 25.205 (72.05%)	36.12M
ZAPPZapp Electric Vehicles Group Ltd	$ 4.35 (52.10%)	461.2k
HWHHWH International Inc	$ 2.6023 (42.98%)	17.84M
CSSEChicken Soup for the Soul Entertainment Inc	$ 0.325 (34.41%)	12.83M
CLVRClever Leaves Holdings Inc	$ 1.55 (-62.29%)	544.71k
ADXNAddex Therapeutics Ltd	$ 8.66 (-46.21%)	91.14k
MFImF International Ltd	$ 1.6296 (-30.06%)	2.2M
TSDDGraniteShares ETF Trust GraniteShares	$ 18.04 (-27.55%)	744.78k
TSLZT Rex 2X Inverse Tesla Daily Target ETF	$ 28.57 (-27.25%)	3.91M
SINTSiNtx Technologies Inc	$ 0.0517 (27.97%)	108.68M
TSLATesla Inc	$ 191.36 (13.71%)	105.44M
CAUDCollective Audience Inc	$ 0.7055 (80.90%)	100.9M
SOFISoFi Technologies Inc	$ 7.07 (-10.17%)	97.77M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	$ 9.12 (27.55%)	43.66M